OPTIMISation of Cardio-renal-metabolic-pulmonary Disease Guideline Adherence in High Risk Community Dwelling Individuals
Launched by UNIVERSITY OF LEEDS · Jun 5, 2024
Trial Information
Current as of February 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
Cardiovascular disease (CVD) causes a quarter of all deaths in the UK and is the largest cause of premature mortality in deprived areas. The National Health Service (NHS) Long Term Plan emphasises that this is the single biggest area where the NHS can save lives and that better detection and treatment of cardiovascular, renal, metabolic and pulmonary risk factors is a priority.
Treatment of blood pressure, cholesterol, diabetes, kidney disease, as well as weight loss in individuals who are obese, have been shown in randomised clinical trials (RCT) to reduce the risk of CVD and cardiovascul...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Consented participants in the FIND-AF study
- • Higher predicted FIND-AF risk according to the FIND-AF score
- Exclusion Criteria:
- • Unable to give written informed consent for participation in the study
- • Unable to adhere to the study requirements
Trial Officials
Chris P. Gale
Principal Investigator
University of Leeds
Ramesh Nadarajah
Principal Investigator
University of Leeds
About University Of Leeds
The University of Leeds is a prestigious research institution located in the United Kingdom, renowned for its commitment to advancing knowledge through innovative research and education. As a clinical trial sponsor, the University of Leeds leverages its diverse expertise and collaborative environment to facilitate high-quality clinical studies that aim to improve health outcomes and contribute to the scientific community. The university fosters interdisciplinary partnerships, ensuring rigorous methodologies and ethical standards in its research initiatives. By integrating cutting-edge technologies and a patient-centered approach, the University of Leeds plays a vital role in translating research findings into practical applications for healthcare improvement.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
People applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Discussion 0